To further define the role of PKMYT1 in regulating CML progression in vivo, an orthotopic xenograft model was established via intravenous (i.v.)injection of K562 tumor cells. The gene discussed is PKMYT1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.